Analysts believe Park Hotels IPO allows investors to invest in the eighth largest hotel chain, which has a diversified portfolio and strategically positions itself in key markets, leveraging an asset-light model.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the